Michelle Bell

New disposable encounter-sensing wristbands unveiled at HIMSS 2026 aim to automate clinical documentation, giving valuable time back to patient care.

After a major clinical trial failure, COSCIENS is shutting down its German pharma unit to focus on its profitable plant-based active ingredients business.

aTyr Pharma heads to a crucial FDA meeting for its lung drug efzofitimod, which missed its main goal but showed significant patient quality-of-life gains.

Sword Health expands its Bloom platform, using AI to offer continuous support for women from fertility to menopause and challenge the fragmented healthcare system.

After a four-year regulatory journey, AquaBoreal's massive salmon farm gets key approval, promising to boost Quebec's food security and revitalize a region.

The U.S. services sector boomed in February, hitting its highest growth in years, but a split economy reveals both soaring industries and struggling sectors.

Beyond just a check, Momentum AMP is embedding its team and training into IndieTech 2027, a strategic move that could reshape agent tech collaboration.

The new president brings a deep background in sustainable tech and operational excellence, signaling a new strategic direction for the Danaher subsidiary.

Norsk Hydro plans to close its Lucé, France extrusion plant, impacting 80 jobs, as part of a wider strategy that has targeted six plants across Europe.

Proofpoint launches its AI-powered Nuclei Suite, offering enterprise-grade compliance tools to resource-strapped small and medium businesses.

A new survey shows older Canadians are more cautious than you think. But with rising fraud, is caution enough without the right technology to fight back?

Churchill Asset Management's top industry award reveals a surging demand for flexible junior capital as private equity navigates a complex market.

Forum Investment Group hires Ares vet Grant Turner in a strategic bid to scale its 1031 exchange platform and capture the booming tax-advantaged market.

Virtus Investment Partners' deal for Keystone National Group signals a major push to bring asset-backed lending to the mainstream wealth channel.

WNC CEO Will Cooper, Jr. is the new chairman of BUILD-PAC. Can his deep affordable housing focus reshape federal policy in a critical election year?

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

A new non-equity partnership aims to leverage AI and automation, reshaping the global digital transformation market and enterprise customer experience.

iQGen's new v1 platform integrates capital, security, and control to streamline distributed energy projects and accelerate the rise of Virtual Power Plants.

National CineMedia's revenue outpaced attendance in a strong Q4, but a full-year loss and weak 2026 forecast raise questions about its future strategy.

The stars join The Elizabeth Taylor AIDS Foundation to modernize laws from the '80s that criminalize HIV status, clashing with modern science.